NASDAQ:DCGO DocGo (DCGO) Stock Forecast, Price & News $9.42 -0.08 (-0.84%) (As of 04:00 PM ET) Add Compare Share Share Today's Range$9.34▼$9.5550-Day Range$7.75▼$9.5052-Week Range$6.36▼$11.41Volume343,496 shsAverage Volume621,890 shsMarket Capitalization$974.69 millionP/E Ratio47.10Dividend YieldN/APrice Target$12.50 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media DocGo MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside32.6% Upside$12.50 Price TargetShort InterestBearish11.34% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.44Based on 5 Articles This WeekInsider TradingSelling Shares$1.12 M Sold Last QuarterProj. Earnings Growth50.00%From $0.28 to $0.42 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.25 out of 5 starsMedical Sector285th out of 986 stocksHealth Services Industry4th out of 13 stocks 3.5 Analyst's Opinion Consensus RatingDocGo has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $12.50, DocGo has a forecasted upside of 32.6% from its current price of $9.43.Amount of Analyst CoverageDocGo has only been the subject of 2 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted11.34% of the float of DocGo has been sold short.Short Interest Ratio / Days to CoverDocGo has a short interest ratio ("days to cover") of 15.1, which indicates bearish sentiment.Change versus previous monthShort interest in DocGo has recently decreased by 2.94%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldDocGo does not currently pay a dividend.Dividend GrowthDocGo does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DCGO. Previous Next 0.9 News and Social Media Coverage News SentimentDocGo has a news sentiment score of -0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for DocGo this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for DCGO on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added DocGo to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, DocGo insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,117,124.00 in company stock.Percentage Held by Insiders13.78% of the stock of DocGo is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 36.88% of the stock of DocGo is held by institutions. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for DocGo are expected to grow by 50.00% in the coming year, from $0.28 to $0.42 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DocGo is 47.15, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.93.Price to Earnings Ratio vs. SectorThe P/E ratio of DocGo is 47.15, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 97.22.Price to Book Value per Share RatioDocGo has a P/B Ratio of 3.47. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About DocGo (NASDAQ:DCGO) StockDocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.Read More Receive DCGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter. Email Address DCGO Stock News HeadlinesJune 9, 2023 | msn.comDocGo: Poised For Success In The Lucrative Virtual Healthcare MarketJune 5, 2023 | finance.yahoo.comDocGo Inc. (DCGO) Reports Q1 Loss, Lags Revenue EstimatesJune 9, 2023 | Behind the Markets (Ad)"Unknown laser company making HUGE profit from Russia-Ukraine War"On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>June 5, 2023 | finance.yahoo.comAre Options Traders Betting on a Big Move in DocGo (DCGO) Stock?June 4, 2023 | americanbankingnews.comComparing DocGo (NASDAQ:DCGO) & InnovAge (OTCMKTS:INNV)June 3, 2023 | americanbankingnews.comAdriaan Stephanus Oberholzer Sells 16,271 Shares of DocGo Inc. (NASDAQ:DCGO) StockMay 30, 2023 | americanbankingnews.comCritical Review: DocGo (NASDAQ:DCGO) versus Xcelerate (OTCMKTS:XCRT)May 28, 2023 | americanbankingnews.comDocGo Inc. (NASDAQ:DCGO) Insider Adriaan Stephanus Oberholzer Sells 7,595 SharesJune 9, 2023 | Behind the Markets (Ad)"Unknown laser company making HUGE profit from Russia-Ukraine War"On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>May 26, 2023 | finance.yahoo.comWith 55% ownership, DocGo Inc. (NASDAQ:DCGO) boasts of strong institutional backingMay 24, 2023 | finance.yahoo.comDocGo Announces Upcoming Participation at Stifel 2023 Cross Sector Insight ConferenceMay 21, 2023 | americanbankingnews.comDocGo Inc. (NASDAQ:DCGO) Director Sells $513,000.00 in StockMay 12, 2023 | americanbankingnews.comQ2 2023 EPS Estimates for DocGo Inc. Cut by Northland Capmk (NASDAQ:DCGO)May 7, 2023 | msn.comEarnings Outlook For DocGoMay 7, 2023 | finance.yahoo.comHow Good Is DocGo Inc. (NASDAQ:DCGO), When It Comes To ROE?May 5, 2023 | finance.yahoo.comDocGo Announces Upcoming Participation at 18th Annual Needham Technology and Media ConferenceMay 4, 2023 | americanbankingnews.comHead-To-Head Comparison: DCC (OTCMKTS:DCCPF) and DocGo (NASDAQ:DCGO)May 3, 2023 | americanbankingnews.comShort Interest in DocGo Inc. (NASDAQ:DCGO) Increases By 8.9%April 29, 2023 | finance.yahoo.comShould You Invest in DocGo (DCGO) for Long-Term Durable Returns?April 25, 2023 | finance.yahoo.comDocGo Announces Strategic Mobile Health Agreement with Fresenius Medical CareApril 25, 2023 | americanbankingnews.comHead to Head Contrast: DocGo (NASDAQ:DCGO) versus Accelera Innovations (OTCMKTS:ACNV)April 24, 2023 | americanbankingnews.comDocGo's (DCGO) "Buy" Rating Reaffirmed at Needham & Company LLCApril 24, 2023 | americanbankingnews.comNeedham & Company LLC Reiterates Buy Rating for DocGo (NASDAQ:DCGO)April 24, 2023 | americanbankingnews.comDocGo's (DCGO) Buy Rating Reaffirmed at Needham & Company LLCApril 24, 2023 | finance.yahoo.comDocGo's (NASDAQ:DCGO) one-year earnings growth trails the shareholder returnsApril 24, 2023 | americanbankingnews.comCritical Comparison: DocGo (DCGO) vs. The CompetitionApril 23, 2023 | americanbankingnews.comDocGo (NASDAQ:DCGO) Now Covered by Analysts at Cantor FitzgeraldSee More Headlines DCGO Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DCGO Company Calendar Last Earnings3/13/2023Today6/09/2023Next Earnings (Estimated)8/14/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Health services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:DCGO CUSIPN/A CIK1822359 Webwww.docgo.com Phone844-443-6246FaxN/AEmployees3,252Year FoundedN/APrice Target and Rating Average Stock Price Forecast$12.50 High Stock Price Forecast$14.00 Low Stock Price Forecast$11.00 Forecasted Upside/Downside+32.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$0.20 Trailing P/E Ratio47.15 Forward P/E Ratio33.68 P/E GrowthN/ANet Income$34.58 million Net Margins4.70% Pretax Margin1.59% Return on Equity7.05% Return on Assets5.15% Debt Debt-to-Equity RatioN/A Current Ratio2.37 Quick Ratio2.37 Sales & Book Value Annual Sales$440.52 million Price / Sales2.21 Cash Flow$0.46 per share Price / Cash Flow20.44 Book Value$2.72 per share Price / Book3.47Miscellaneous Outstanding Shares103,470,000Free Float89,215,000Market Cap$975.72 million OptionableNot Optionable Beta0.93 Key ExecutivesMr. Stan Vashovsky (Age 50)Co-Founder & Non-Exec. Chairman Comp: $3.08MMr. Anthony Capone (Age 35)Chief Exec. Officer Comp: $1.62MMr. Andre Oberholzer CPA (Age 65)Chief Financial Officer Comp: $1.75MMr. Ely D. Tendler (Age 55)Gen. Counsel, Sec. & Director Mr. Lee Bienstock (Age 39)Pres & Chief Operating Officer Mr. Norman Rosenberg (Age 54)Chief Financial Officer Mr. Stephen Sugrue (Age 51)Chief Compliance Officer Mr. Ben ShermanEVP of Corp. Devel.Ms. Rosemarie MilanoVP of HRDr. Mark Merlin (Age 55)Chief Medical Officer of Ambulnz Holdings, LLC More ExecutivesKey CompetitorsSharecareNASDAQ:SHCRU.S. Physical TherapyNYSE:USPHThe Pennant GroupNASDAQ:PNTGP3 Health PartnersNASDAQ:PIIIMorphoSysNASDAQ:MORView All CompetitorsInsiders & InstitutionsAdriaan Stephanus OberholzerSold 42,497 sharesTotal: $385,447.79 ($9.07/share)Adriaan Stephanus OberholzerSold 16,271 sharesTotal: $146,764.42 ($9.02/share)Adriaan Stephanus OberholzerSold 300 sharesTotal: $2,721.00 ($9.07/share)Adriaan Stephanus OberholzerSold 7,595 sharesTotal: $69,190.45 ($9.11/share)Royce & Associates LPBought 249,000 shares on 5/23/2023Ownership: 0.241%View All Insider TransactionsView All Institutional Transactions DCGO Stock - Frequently Asked Questions Should I buy or sell DocGo stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DocGo in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" DCGO shares. View DCGO analyst ratings or view top-rated stocks. What is DocGo's stock price forecast for 2023? 2 equities research analysts have issued 12 month price objectives for DocGo's shares. Their DCGO share price forecasts range from $11.00 to $14.00. On average, they expect the company's share price to reach $12.50 in the next twelve months. This suggests a possible upside of 32.6% from the stock's current price. View analysts price targets for DCGO or view top-rated stocks among Wall Street analysts. How have DCGO shares performed in 2023? DocGo's stock was trading at $7.07 at the beginning of the year. Since then, DCGO stock has increased by 33.4% and is now trading at $9.43. View the best growth stocks for 2023 here. When is DocGo's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023. View our DCGO earnings forecast. How were DocGo's earnings last quarter? DocGo Inc. (NASDAQ:DCGO) issued its earnings results on Monday, March, 13th. The company reported $0.11 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.06. The firm had revenue of $108.79 million for the quarter, compared to the consensus estimate of $104.13 million. DocGo had a trailing twelve-month return on equity of 7.05% and a net margin of 4.70%. During the same quarter in the prior year, the company earned $0.17 earnings per share. What ETFs hold DocGo's stock? ETFs with the largest weight of DocGo (NASDAQ:DCGO) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Janus Henderson Small Cap Growth Alpha ETF (JSML), SPDR S&P Health Care Services ETF (XHS), Hartford Multifactor Small Cap ETF (ROSC), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), Invesco Dynamic Market ETF (PWC) and iShares Micro-Cap ETF (IWC).iShares U.S. Healthcare Providers ETF (IHF). What guidance has DocGo issued on next quarter's earnings? DocGo updated its FY 2023 earnings guidance on Monday, May, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $500.00 million-$510.00 million, compared to the consensus revenue estimate of $504.42 million. What is DocGo's stock symbol? DocGo trades on the NASDAQ under the ticker symbol "DCGO." Who are DocGo's major shareholders? DocGo's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (5.52%), Hood River Capital Management LLC (5.43%), Portolan Capital Management LLC (1.99%), Punch & Associates Investment Management Inc. (1.93%), State Street Corp (1.87%) and Emerald Advisers LLC (1.77%). Insiders that own company stock include Adriaan Stephanus Oberholzer and James M Travers. View institutional ownership trends. How do I buy shares of DocGo? Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is DocGo's stock price today? One share of DCGO stock can currently be purchased for approximately $9.43. How much money does DocGo make? DocGo (NASDAQ:DCGO) has a market capitalization of $975.72 million and generates $440.52 million in revenue each year. The company earns $34.58 million in net income (profit) each year or $0.20 on an earnings per share basis. How many employees does DocGo have? The company employs 3,252 workers across the globe. How can I contact DocGo? The official website for the company is www.docgo.com. The company can be reached via phone at 844-443-6246 or via email at ir@docgo.com. This page (NASDAQ:DCGO) was last updated on 6/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.